Influence of urokinase on cell proliferation and invasion
- PMID: 1966799
Influence of urokinase on cell proliferation and invasion
Abstract
The urokinase-dependent plasminogen activating system is regulated not only by zymogen to enzyme conversion of pro-urokinase and inhibition of the active enzyme by plasminogen activator inhibitors, but also by regulated expression of urokinase receptors on the cell surface. Receptor-bound pro-urokinase in turn becomes activated and is capable of activating plasminogen probably bound site by site to urokinase to a cell surface receptor. Plasmin by itself or via activation of pro-collagenase to collagenase is capable of degrading the extracellular matrix, in turn mediating processes like invasion, metastasis and tumour growth. In addition, in some cell lines the urokinase-dependent system mediated via receptor-bound active urokinase is also capable of eliciting a mitogenic response of the cells. Therefore, the urokinase-dependent plasminogen activating system might not only be responsible for mediating extravascular proteolysis but might also be an autocrine mitogen for some cell lines.
Similar articles
-
Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1.Cancer Res. 1992 Jun 1;52(11):3043-7. Cancer Res. 1992. PMID: 1375533
-
Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.J Pept Sci. 2000 Sep;6(9):432-9. doi: 10.1002/1099-1387(200009)6:9<432::AID-PSC279>3.0.CO;2-Q. J Pept Sci. 2000. PMID: 11016879
-
Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness.Bioessays. 1993 Feb;15(2):105-11. doi: 10.1002/bies.950150206. Bioessays. 1993. PMID: 8385942 Review.
-
Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.Cancer Res. 2003 Aug 1;63(15):4648-55. Cancer Res. 2003. PMID: 12907645
-
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review.
Cited by
-
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.Thorax. 1999 Feb;54(2):169-79. doi: 10.1136/thx.54.2.169. Thorax. 1999. PMID: 10325924 Free PMC article. Review. No abstract available.
-
A novel mechanism of plasmin-induced mitogenesis in fibroblasts.J Thromb Haemost. 2005 Jan;3(1):163-9. doi: 10.1111/j.1538-7836.2004.01054.x. J Thromb Haemost. 2005. PMID: 15634280 Free PMC article.
-
Lysosome labilizers potentiate the antitumor effects of tumor necrosis factor-alpha.Jpn J Cancer Res. 1993 Apr;84(4):451-4. doi: 10.1111/j.1349-7006.1993.tb00157.x. Jpn J Cancer Res. 1993. PMID: 8514612 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources